This document summarizes the re-regulation of the pharmacy market in Sweden and its consequences for hospital pharmacies, with a focus on compounding medicines. It describes the current model where hospital pharmacy services are contracted out to various private and public providers through a competitive tendering process. This model has led to both benefits like lower prices through competition, and challenges like increased fragmentation and less collaboration between players. The document also outlines the roles of different organizations in developing hospital pharmacy practices in Sweden.